Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F. Shern, Javed Khan, Jun S. Wei et al.|Journal of Clinical Oncology|2021Cited by 221
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Janet Shipley, Corinne M. Linardic et al.|European Journal of Cancer|2022Cited by 73
Requirement for DNA Ligase IV during Embryonic Neuronal DevelopmentSusanne A. Gatz, Penelope A. Jeggo, Ju Lu et al.|Journal of Neuroscience|2011Cited by 65
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targetingSilvia Pomella, Rossella Rota, Matteo Cassandri et al.|Nature Communications|2023Cited by 24